Topic Review
Methods for DDIs Mediated by Renal Transporters
Drug–drug interactions (DDIs) are a key issue in clinical rational administration and post-marketing pharmacovigilance. Since the 1980s, with the development of molecular biology, the study of renal transporters has made rapid progress. The exploration of these transporters has helped to improve drug safety and efficacy, played an important role in understanding drug toxicity and DDIs, and also provided a theoretical basis for improving drug targeting. Regarding renal transporters, researchers and drug discovery scientists have studied a lot in the field of their mediated DDIs, from traditional models to recent biomarker methods and in silico models.
  • 310
  • 21 Jul 2023
Topic Review
Nefroprotective Potential of Amazonian Plant Species
There are several Amazonian plant species with potential pharmacological validation for the treatment of acute kidney injury, a condition in which the kidneys are unable to adequately filter the blood, resulting in the accumulation of toxins and waste in the body. 
  • 307
  • 14 Sep 2023
Topic Review
Development of Nitroheterocyclic Drugs against Trypanosomes
Human African Trypanosomiasis (HAT), commonly called sleeping sickness, is a zoonotic disease caused by different subspecies of the bloodstream parasite T. brucei and transmitted by the Glossina tsetse fly. Nitroaromatic rings are privileged pharmacophores of many antimicrobials in clinical use, including antifungal and antiparasitic drugs.
  • 305
  • 10 Apr 2023
Topic Review
Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke
Stroke is one of the main causes of mortality and disability, and it is due to be included in monetary implications on wellbeing frameworks around the world. Ischemic stroke is caused by interference in cerebral blood flow, leading to a deficit in the supply of oxygen to the affected region. It accounts for nearly 80–85% of all cases of stroke. Oxidative stress has a significant impact on the pathophysiologic cascade in brain damage leading to stroke. In the acute phase, oxidative stress mediates severe toxicity, and it initiates and contributes to late-stage apoptosis and inflammation. Oxidative stress conditions occur when the antioxidant defense in the body is unable to counteract the production and aggregation of reactive oxygen species (ROS).
  • 304
  • 17 Mar 2023
Topic Review
Therapeutic Cancer Vaccines
Vaccines have played a significant role in protecting public and personal health against infectious diseases and proved their great potential in battling cancers as well. 
  • 303
  • 20 Jul 2022
Topic Review
Risk of Adverse Drug Reactions in Elderly Population
The European Medicine Agency (EMA) has defined Adverse Drug Reactions (ADRs) as “a noxious and unintended response to a medicine”, not including poisoning, accidental, or intentional overdoses. The ADR occurrence differs based on the approach adopted for defining and detecting them, the characteristics of the population under study, and the research setting. ADRs have a significant impact on morbidity and mortality, particularly among older adults, and represent a financial burden for health services.
  • 303
  • 09 Nov 2023
Topic Review
Drug Therapies for Diabetes
The treatment of type 2 diabetes (T2D) necessitates a multifaceted approach that combines behavioral and pharmacological interventions to mitigate complications and sustain a high quality of life. Treatment encompasses the management of glucose levels, weight, cardiovascular risk factors, comorbidities, and associated complications through medication and lifestyle adjustments. Metformin, a standard in diabetes management, continues to serve as the primary, first-line oral treatment across all age groups due to its efficacy, versatility in combination therapy, and cost-effectiveness. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) offer notable benefits for HbA1c and weight reduction, with significant cardiovascular benefits. Sodium-glucose cotransporter inhibitors (SGLT-2i) lower glucose levels independently of insulin while conferring notable benefits for cardiovascular, renal, and heart-failure outcomes. Combined therapies emphasizing early and sustained glycemic control are promising options for diabetes management. As insulin therapy remains pivotal, metformin and non-insulin agents such as GLP-1 RA and SGLT-2i offer compelling options. Notably, exciting novel treatments like the dual GLP-1/ glucose-dependent insulinotropic polypeptide (GIP) agonist show promise for substantially reducing glycated hemoglobin and body weight.
  • 300
  • 03 Jan 2024
Topic Review
Potassium Ion Channels in Glioma
Ion channels are transmembrane proteins that create a regulated pore structure through which ions can pass across the lipid bilayer of biological membranes. Ion channels, specifically those controlling the flux of potassium across cell membranes, have been shown to exhibit an important role in the pathophysiology of glioma, the most common primary central nervous system tumor with a poor prognosis.
  • 300
  • 25 Apr 2023
Topic Review
Sodium-Dependent Organic Anion Transporter
The sodium-dependent organic anion transporter (SOAT, gene symbol SLC10A6) specifically transports 3′- and 17′-monosulfated steroid hormones, such as estrone sulfate and dehydroepiandrosterone sulfate, into specific target cells. These biologically inactive sulfo-conjugated steroids occur in high concentrations in the blood circulation and serve as precursors for the intracrine formation of active estrogens and androgens that contribute to the overall regulation of steroids in many peripheral tissues.
  • 300
  • 14 Jun 2023
Topic Review
Peripheralization Strategies Applied to Morphinans
Among therapeutically valuable opioids, morphinans are of the utmost clinical importance as analgesic drugs because of their agonistic actions to the mu-opioid receptor. They include powerful pain relieving agents, such as naturally occurring alkaloids (e.g., morphine and codeine), semisynthetic analogues (e.g., hydrocodone, hydromorphone, oxycodone, oxymorphone and buprenorphine), and synthetic derivatives (e.g., levorphanol).
  • 301
  • 29 Jun 2023
  • Page
  • of
  • 106
Video Production Service